Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Bita Fakhri, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Bita Fakhri, MD
Assistant Professor, Medicine. Authored (or co-authored) 18 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Angiocrine Bioscience
- ID
- NCT03925935
- Phase
- Phase 1
- Study Type
- Interventional
- Last Updated